Absorption, Distribution and Excretion of Orbifloxacin in Dogs and Cats

  • MATSUMOTO Shuji
    Research Laboratories, Animal Science Division, Dainippon Pharmaceutical Co., Ltd.
  • TAKAHASHI Miyuki
    マルピー・ライフテック (株)
  • YOSHIDA Motonobu
    Research Laboratories, Animal Science Division, Dainippon Pharmaceutical Co., Ltd.
  • KOMATSU Tadato
    Research Laboratories, Animal Science Division, Dainippon Pharmaceutical Co., Ltd.
  • KITADAI Yoshiyuki
    Research Laboratories, Animal Science Division, Dainippon Pharmaceutical Co., Ltd.
  • HORII Yoshihiro
    Research Laboratories, Animal Science Division, Dainippon Pharmaceutical Co., Ltd.
  • KATAE Hiromi
    Research Laboratories, Animal Science Division, Dainippon Pharmaceutical Co., Ltd.

Bibliographic Information

Other Title
  • 犬および猫におけるオルビフロキサシンの血漿中および組織中濃度ならびにその排泄
  • イヌ オヨビ ネコ ニ オケル オルビフロキサシン ノ ケッショウ チュウ オ

Search this article

Abstract

Absorption, distribution and excretion of a new quinolon derivative, orbifloxacin (OBFX), were studied in dogs and cats given a single dose of 5mg/kg. The pharmacokinetic parameters of OBFX were almost similar after either subcutaneous or oral route administration. The AUC0-∞ in cats given intravenous, subcutaneous and oral doses were almost the same. The satisfactory distribution of OBFX was observed in various tissues of dogs and cats given subcutaneous dose, and the levels were higher than the plasma levels in most of tissues. After subcutaneous injection of OBFX, the urinary recoveries (0-72hrs) were 45.4% and 28.3%, in dogs and cats respectively, while the fecal recoveries were 17.7% and 15.4%.

Journal

Citations (4)*help

See more

References(6)*help

See more

Details 詳細情報について

Report a problem

Back to top